Table 3.
Effectivenness of PRP in adhesive capsulitis.
Study | Study design | Patients enrolled | Outcome | Use of PRP | ||||
---|---|---|---|---|---|---|---|---|
Total | PRP | CS | UT | Control | ||||
Aslani et al. (61) | CR | 1 | 60% improvement of diurnal shoulder pain. Two-fold improvement for ROM and more than 70% improvement for function | + | ||||
Ünlü et al. (62) | RCT | 32 | 17 | 15 | L-PRP was effective in both pain and disability and improved ROM | + (L-PRP) | ||
Barman et al. (63) | PCS | 55 | 28 | 27 | P-PRP was more effective than CS in terms of improving pain, disability, and ROM in 12 weeks FU | + (P-PRP) | ||
Lee et al. (64) | CLSCS | 30 | 15 | 15 | P-PRP decreased pain and improved shoulder ROM and function comparable with that of a corticosteroid | + (P-PRP) | ||
Kothari et al. (65) | RCT | 180 | 62 | 60 | 58 | Single injection of PRP (preparation not defined) is effective and better than CS or ultrasonic therapy | + | |
Çaliş et al. (66) | ICS | 9 | Significant improvements in VAS scores, Shoulder Pain and Disability Index scores and ROM in all time points when compared with baseline | + |
+, support the use of PRP.
CLSCS, controlled laboratory study and cohort study; CR, case report; FU, follow-up; ICS, interventional case series; PCS, prospective cohort study; UT, ultrasound therapy.